BRIEF INFORMATION ON THE PREPARATION Form of issue: aerosol for topical application 30 g. Composition: active substance, biclotymol 0.75 g Pharmacological properties: has antimicrobial effect (active against staphylococci, streptococci and corynebacteria), local anesthetic, anti-inflammatory and analgesic effect. Indications: infectious and inflammatory diseases of the oral cavity, pharynx, larynx, caused by pathogens sensitive to biclotymol. Local treatment of inflammatory and infectious diseases of the nasopharynx and respiratory tract (acute and chronic pharyngitis, pharyngolaryngitis, tonsillitis, conditions after tonsillectomy, glossitis). Dosage and administration: topically for adults and children from 3 years old: 2 sprays 3 times a day. The duration of treatment should not exceed 5 days. Side effects: - possible: allergic reactions (skin rash, itching, swelling of the lips, erythema, Quincke's edema). Contraindications: children under 3 years of age, hypersensitivity to the components of the drug. Special instructions: keep the bottle upright during spraying. Shake the bottle before use. Pregnancy and lactation: the use of the drug during pregnancy and lactation is possible if the intended benefit to the mother outweighs the risk to the fetus and child Conditions for dispensing from pharmacies: without a prescription
TRADE NAME: Isofra INTERNATIONAL NON-PROPERTY NAME: Framycetin DOSAGE FORM: Nasal spray 15 ml, 1, 25% 1 SPRAY DOSE CONTAINS: active substance - framycetin sulfate 1.25 g which corresponds to 800 000 IU, description of colorless liquid: Transparent pharmaceutical antibiotic from the group of aminoglycosides for topical use in otolaryngology. It has a bactericidal effect. It is active against most gram-positive and gram-negative bacteria (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae), which cause the development of infectious processes in the upper respiratory tract. SIDE EFFECTS Rarely - allergic reactions: skin rash, itching CONTRAINDICATIONS - Hypersensitivity to framycetin and other antibiotics from the aminoglycoside group. The drug should not be used to flush the paranasal sinuses. - pregnancy and lactation. DRUG INTERACTIONS: no clinically significant drug interactions with other drugs have been identified. SPECIAL INSTRUCTIONS: it should be remembered that during the treatment, the appearance of resistant strains of microorganisms is possible. PREGNANCY: contraindicated during pregnancy and during breastfeeding. LACTATION PERIOD: Use of this drug is not recommended during breastfeeding because aminoglycosides pass into breast milk. Features of the effect of the drug on the ability to drive a vehicle or potentially dangerous mechanisms: does not affect OVERDOSE Symptoms - currently no cases of overdose have been reported. Treatment - symptomatic. ISSUE FORM AND PACKAGING 15 ml in polyethylene light-proof vials with a spray tip with a plastic screw cap, 1 vial with instructions for use is placed in a cardboard box. STORAGE conditions: out of the reach of children at a temperature not exceeding 25 ° C. STORAGE LIFE: 3 years. Do not use after the expiration date. Terms of RELEASE FROM PHARMACIES: by prescription MANUFACTURER: Sopartex 21 rue du Presseau, Vernouillet 28500, Paris, France from consumers and responsible for post-registration monitoring of the safety of the medicinal product: 000 “Sorrento Medical”, Amir Temur street 51-A, S Tashkent, Republic of Uzbekistan, tel .: +998 712 309 586, e-mail: firstname.lastname@example.org (email@example.com).
Trade name Terzhinan International non-proprietary name No Dosage form Vaginal tablets Composition One tablet contains active substances: ternidazole 200 mg, neomycin sulfate 100 mg or 65,000 IU, nystatin 100,000 ME, prednisolone in the form of sodium metasulfobenzoate 3 mg Indications for use Treatment of vaginitis caused by microorganisms sensitive to the drug: - bacterial, incl. called Trichomonas vaginalis; - fungal, caused by yeast-like fungi of the genus Candida; - mixed; prevention of vaginitis: - before gynecological operations; - before childbirth and abortion; - before and after the installation of intrauterine devices; - before and after diathermocoagulation of the cervix; - before hysterography. Method of administration and dosage One tablet is injected deep into the vagina in the supine position before bedtime. Before insertion into the vagina, the tablet should be soaked in water (within 20-30 seconds). After administration of the drug, you should remain in a horizontal position for 10-15 minutes. The average duration of treatment is 10 days.
Side effects - burning sensation, itching and irritation in the vagina (especially at the beginning of treatment) - in some cases, allergic reactions are possible (skin rash, itching). Contraindications - hypersensitivity to drug components. Drug interactions Not established Special instructions In the case of treatment of vaginitis, trichomoniasis, simultaneous treatment of sexual partners is recommended. You should not stop treatment during your period. Application in pediatrics The drug is not used in pediatric practice Pregnancy and lactation The use of the drug during pregnancy and lactation is possible only in cases where the potential benefit to the mother outweighs the risk to the fetus or baby. Peculiarities of the influence of the drug on the ability to drive a vehicle or potentially dangerous mechanisms Does not affect Pharmacy dispensing conditions Without a prescription Producer SOFARTEX 21 rue du Presseau, 28500 Vernouillet, France for the BOUCHAR RECORDATY laboratory 68 Marjolen 92300 Levallois-Perret, France
Klimalanin, a non-hormonal drug used to treat hot flashes during menopause
Release form - tablets No. 30
Composition - beta-alanine, 400 mg
It is used for contraindications to MHT, side effects while taking MHT, in combination with other drugs with insufficient relief of the latter tides. In combination with estrogens to reduce the dose of the latter. With a genetic predisposition to "hot flashes" - polymorphism of genes CYP1B1, CYP19, ERbeta, ERalpha